5α-reductase can convert testosterone into dihydrotestoterone (DHT), which subsequently binds to the androgen receptor (AR) (a ligand-dependent transcriptional factor), contributing to prostate cancer development and progression [14]. The gene discussed is AR; the disease is prostate carcinoma.